Don Healey Insider Profile

11 Followers
Don Healey, Chief Scientific Officer at Acer Therapeutics, holds 72.33K shares in Adicet Bio (Ticker: ACET), holds 4.04K shares in Acer Therapeutics (Ticker: ACER).
tipranks
Don Healey

Don Healey
Acer Therapeutics (ACER)
Chief Scientific Officer

Not Ranked
Don Healey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$90K
100.00%
A breakdown of Don Healey's holdings

Insider Roles

Adicet Bio
(ACET)
CTO
Roles that Don Healey holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Don Healey

Don Healey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACER
Acer Therapeutics
Nov 03, 2015
Uninformative Buy
$2.67K
Adicet Bio
Jan 26, 2024
CTO
Uninformative Buy
$90.41K
List of latest transactions for each holding click on a transaction to see Don Healey's performance on stock

Don Healey insider profile FAQ

What is the percentage of profitable transactions made by Don Healey?
The percentage of profitable transactions made by Don Healey is ―.
    What is the average return per transaction made by Don Healey?
    The average return per transaction made by Don Healey is ―.
      What stocks does Don Healey hold?
      Don Healey holds: ACER, ACET stocks.
        What was Don Healey’s latest transaction?
        Don Healey latest transaction was an Uninformative Buy of ―.
          What was Don Healey's most profitable transaction?
          Don Healey’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Don Healey's role in Acer Therapeutics?
            Don Healey's role in Acer Therapeutics is Chief Scientific Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.